ACRO Biomedical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-82.66	-62.09	-41.42	-60.88	-50.78
Depreciation & Amortization	16.53	11.78	9.71	8.24	9.48
Other Amortization	-	1.7	1.27	0.98	0.03
Loss (Gain) From Sale of Assets	0.02	0.15	-	-	-
Loss (Gain) From Sale of Investments	-1.4	1.33	-2.77	-0.5	-1.81
Stock-Based Compensation	2.63	1.39	-	0.74	1.39
Provision & Write-off of Bad Debts	-0.67	-1.85	3.55	-	0
Other Operating Activities	15.43	0.35	-20.46	4	0.53
Change in Accounts Receivable	5.41	-2.56	2.32	-5.01	-0.46
Change in Inventory	-8.12	-1.72	2.9	-1.96	-1.69
Change in Accounts Payable	0.28	0.36	0.09	0.24	-0.13
Change in Unearned Revenue	-1.61	2.31	0.12	-0.23	-2.86
Change in Other Net Operating Assets	5.14	5.47	-3.58	9.24	-1.52
Operating Cash Flow	-49.01	-43.38	-48.27	-45.15	-47.83
Capital Expenditures	-12.82	-30.55	-21	-2.74	-0.37
Sale of Property, Plant & Equipment	-	0.02	-	-	-
Sale (Purchase) of Intangibles	-1.14	-0.08	-1.46	-1.7	-2.93
Investment in Securities	100	-272.13	-10.6	-4.1	40.21
Other Investing Activities	-1.64	-1.92	-0.54	-2.01	-0.05
Investing Cash Flow	84.41	-304.67	-33.59	-10.54	36.86
Long-Term Debt Repaid	-5.26	-5.25	-4.72	-3.45	-3.42
Net Debt Issued (Repaid)	-5.26	-5.25	-4.72	-3.45	-3.42
Issuance of Common Stock	550.02	-	350	307.85	-
Financing Cash Flow	544.76	-5.25	345.28	304.4	-3.42
Foreign Exchange Rate Adjustments	-1.23	0.89	-1.1	0.88	1
Net Cash Flow	578.93	-352.41	262.31	249.58	-13.4
Free Cash Flow	-61.83	-73.93	-69.27	-47.89	-48.2
Free Cash Flow Margin	-161.62%	-167.13%	-135.66%	-173.30%	-220.80%
Free Cash Flow Per Share	-1.01	-1.21	-1.31	-1.01	-1.36
Cash Interest Paid	-	0.29	0.26	0.1	0.09
Cash Income Tax Paid	-	0.27	0.17	0.06	-
Levered Free Cash Flow	-48.47	-54.55	-36.11	-27.51	-32.07
Unlevered Free Cash Flow	-48.33	-54.37	-35.95	-27.45	-32.02
Change in Working Capital	1.1	3.86	1.86	2.28	-6.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.